Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesions with ulceration mostly located on the trunk or thigh. Current knowledge about physiopathology, diagnostic practice and therapeutic is very limited. Actually there is no European study about calciphylaxis and risk factors, diagnostic practice and outcome factors.
Study Type
OBSERVATIONAL
Enrollment
80
Description of calcific uremic arteriolopathy in a French population by describing the characteristics of the population, diagnostic and treatment practices and patient outcome.
Time frame: Up to 16 months
Study factors determining the patient outcome with calciphylaxis
Time frame: Up to 16 months
Study case control of risk factors in the subgroup of patients in extra renal replacement therapy
Time frame: Up to 16 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.